Stocks That Hit 52-Week Lows On Tuesday
Tuesday's morning session saw 84 companies set new 52-week lows.
Akari Therapeutics Announced Updates On Progress In The Pre-clinical Development Program For Long-Acting PAS-Nomacopan As A Potential Treatment For Geographic Atrophy Secondary To Dry Age-related Macular Degeneration
Akari is targeting an Investigational New Drug application submission to the FDA in the first half of 2024.
Composition of matter patent application filed on long-acting PAS-nomacopan versions, which, if granted,
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical machining.
12 Health Care Stocks Moving In Tuesday’s Intraday Session
Gainers Otonomy (NASDAQ:OTIC) shares increased by 114.7% to $0.23 during Tuesday’s regular session. The current volume of 184.8…
Why Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday’s Mid-Day Session
Gainers
Peak Bio, Inc. (NYSE: PKBO) shares jumped 49.1% to $7.08.
Akari Therapeutics Announces Receipt Of Nasdaq Minimum Bid Price Notification
Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that Akari received a letter from Nasdaq Listing
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 517 companies set new 52-week lows.
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
S&P 500 Rises 1%, InMed Pharmaceuticals Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 200 points on Monday.